Clinical Trial Update: A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating maribavir for cytomegalovirus infection in Chinese adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Maribavir (maribavir)

Snippet

Sponsor: Takeda | Conditions: Cytomegalovirus (CMV) | Phase 3 | Status: RECRUITING